MARKET

ABBV

ABBV

Abbvie Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

155.90
+3.41
+2.24%
Opening 11:48 06/29 EDT
OPEN
153.99
PREV CLOSE
152.49
HIGH
156.04
LOW
153.35
VOLUME
2.01M
TURNOVER
164.04M
52 WEEK HIGH
175.91
52 WEEK LOW
105.56
MARKET CAP
275.49B
P/E (TTM)
22.36
1D
5D
1M
3M
1Y
5Y
AbbVie names new CFO
AbbVie (NYSE:ABBV) announced the appointment of Scott Reents as its new Chief Financial Officer replacing Robert A. Michael who has been named the company’s Vice Chairman and President effective June
Seekingalpha · 1d ago
AmerisourceBergen, McKesson, Cardinal to pay Oklahoma $250M to resolve opioid claims
Oklahoma reached a $250M settlement with AmerisourceBergen (NYSE:ABC), McKesson (NYSE:MCK) and Cardinal (NYSE:CAH) to resolve claims that the drug distributors fueled the opioid crisis. "Money cannot possibly heal those wounds or
Seekingalpha · 1d ago
AbbVie (ABBV) Gains As Market Dips: What You Should Know
In the latest trading session, AbbVie (ABBV) closed at $153.14, marking a +0.53% move from the previous day.
Zacks · 1d ago
AbbVie's (ABBV) Rinvoq Gets CHMP Nod for New Indication
The CHMP recommends approval of AbbVie's (ABBV) Rinvoq for treating adults with active non-radiographic axial spondyloarthritis.
Zacks · 2d ago
Investors are Watching These 10 Biotech Stocks
In this article, we discuss the 10 biotech stocks that investors are watching. If you want to read about some more biotech stocks, go directly to Investors are Watching These 5 Biotech Stocks. The stock market plunge in the past few weeks because of soarin...
Insider Monkey · 2d ago
AbbVie Rallies After Its Test of the Rising 200-Day Moving Average Line
AbbVie ABBV is a research-based biopharmaceutical company known for its blockbuster drug Humira. In this daily bar chart of ABBV, below, we can see that prices rallied back above the 50-day moving average line after touching/testing the rising 200-day lin...
TheStreet.com · 2d ago
Approximately 15,000 AbbVie Employees to Volunteer Globally to Support Local Communities in Annual Week of Possibilities
AbbVie kicks off its seventh Week of Possibilities today with approximately 15,000 employees volunteering in more than 50 countries to serve local communities around the world. From June 27 to July 1, AbbVie employees will work with trusted community partn...
PR Newswire · 2d ago
BRIEF-Abbvie Says CHMP Recommends Approval Of Upadacitinib (Rinvoq®) For Treatment Of Adults With Active Non-Radiographic Axial Spondyloarthritis
reuters.com · 2d ago
More
No Data
Learn about the latest financial forecast of ABBV. Analyze the recent business situations of Abbvie Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 26 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

15.38%Strong Buy
53.85%Buy
26.92%Hold
3.85%Under-perform
0.00%Sell
Analyst Price Target
The average ABBV stock price target is 163.01 with a high estimate of 200.00 and a low estimate of 135.00.
High200.00
Average163.01
Low135.00
Current 155.55
EPS
Actual
Estimate
0.861.722.573.43
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 3.78K
Institutional Holdings: 1.31B
% Owned: 73.89%
Shares Outstanding: 1.77B
TypeInstitutionsShares
Increased
1.11K
72.13M
New
210
2.32M
Decreased
1.29K
47.98M
Sold Out
119
9.80M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.91%
Pharmaceuticals & Medical Research
+0.84%
Key Executives
Chairman/Chief Executive Officer/Director
Richard Gonzalez
Vice Chairman/Chief Financial Officer/Director
Robert Michael
Vice Chairman - Management
Laura Schumacher
Chief Human Resource Officer/Executive Vice President
Timothy Richmond
Executive Vice President
Henry Gosebruch
Executive Vice President
Azita Saleki - Gerhardt
Executive Vice President
Jeffrey Stewart
Senior Vice President
Thomas Hudson
Senior Vice President
Elaine Sorg
Senior Vice President
Carrie Strom
Vice President/Controller
Brian Durkin
Lead Director/Independent Director
Glenn Tilton
Independent Director
Robert Alpern
Independent Director
Roxanne Austin
Independent Director
William Burnside
Independent Director
Thomas Freyman
Independent Director
Brett Hart
Independent Director
Melody Meyer
Independent Director
Edward Rapp
Independent Director
Rebecca Roberts
Independent Director
Frederick Waddell
No Data
No Data
About ABBV
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Webull offers kinds of AbbVie Inc stock information, including NYSE:ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.